Clin2
NCT06746831Possibly a fitNot yet recruiting

Methamphetamine isomers: how the brain responds

Methamphetamine

Part of Mental health clinical trials.

This study tests how different forms of methamphetamine affect the body and mind in healthy volunteers. The goal is to understand basic brain chemistry without any medical conditions or drug use.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
17 people
Ages
21 years to 64 years
Study type
Interventional

Who can take part

  • You must be in good mental health, with no psychiatric conditions.
  • You must have no major health issues like heart, liver, or kidney disease.
  • You must be able to speak English and give written consent.
  • You cannot have had a bad reaction to similar drugs before.
  • You cannot currently have or have had a substance use disorder.
  • You cannot be pregnant or breastfeeding, and must stop certain meds for 48 hours before visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York
NCT06721494Recruiting· Phase 2
A single-dose study of CS-1103 for methamphetamine use

This trial tests a single dose of an investigational drug, CS-1103, to see if it is safe and effective for people who use methamphetamine. It may help understand how the drug affects methamphetamine in the body.

Glendale, California
NCT06457230Recruiting
Brain stimulation for methamphetamine use disorder

This study tests a new type of non-invasive brain stimulation (transcranial magnetic stimulation) that targets the cerebellum and prefrontal cortex to help people with methamphetamine use disorder. It aims to see if this treatment can reduce cravings and improve outcomes.

Shanghai, Shanghai Municipality
NCT06457243Recruiting
Brain stimulation for methamphetamine use disorder

This trial tests a type of brain stimulation (called cTBS) to see if it can reduce methamphetamine cravings and improve thinking. If you are in recovery or still using, you may be able to join.

Shanghai, Shanghai Municipality
NCT06712446Recruiting
Brain stimulation plus future thinking for methamphetamine use

This study tests whether combining a non-invasive brain stimulation technique (TMS) with a mental exercise called 'episodic future thinking' can help people reduce methamphetamine use. TMS uses magnetic pulses to stimulate brain areas linked to addiction, and episodic future thinking involves imagining positive future events to reduce cravings.

Houston, Texas
NCT07584369Not yet recruiting· Phase 4
How methamphetamine affects HIV in stable patients

This study gives HIV-positive people who are doing well on HIV medication a small dose of methamphetamine to see how it affects their virus and immune system. Researchers want to understand if methamphetamine can wake up hidden HIV that's not being detected.

San Francisco, California

Hear when a new Methamphetamine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.